Norges Bank
DYN icon

Norges Bank’s Dyne Therapeutics DYN Stock Holding History

Norges Bank’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-49,319
Closed -$965K – 423
2025
Q4 		$965K Buy
+49,319
New +$934K ﹤0.01% 1518
2025
Q3 		– Sell
-49,319
Closed -$470K – 475
2025
Q2 		$470K Sell
49,319
-60,603
-55% -$667K ﹤0.01% 1634
2025
Q1 		$1.15M Sell
109,922
-840,182
-88% -$12M ﹤0.01% 1605
2024
Q4 		$22.4M Buy
950,104
+517,777
+120% +$15.3M ﹤0.01% 1214
2024
Q3 		$15.5M Buy
432,327
+325,238
+304% +$12.9M ﹤0.01% 1271
2024
Q2 		$3.78M Buy
107,089
+59,831
+127% +$1.74M ﹤0.01% 1616
2024
Q1 		$1.34M Buy
+47,258
New +$1.07M ﹤0.01% 1773
2023
Q3 		– Sell
-195,600
Closed -$2.2M – 1986
2023
Q2 		$2.2M Sell
195,600
-168,000
-46% -$1.98M ﹤0.01% 1862
2023
Q1 		$4.19M Buy
363,600
+205,848
+130% +$2.67M ﹤0.01% 1804
2022
Q4 		$1.83M Buy
+157,752
New +$1.83M ﹤0.01% 1983
2022
Q2 		– Sell
-600,000
Closed -$5.78M – 2089
2022
Q1 		$5.78M Sell
600,000
-103,400
-15% -$880K ﹤0.01% 1843
2021
Q4 		$8.36M Sell
703,400
-13,700
-2% -$193K ﹤0.01% 1810
2021
Q3 		$11.6M Buy
717,100
+117,100
+20% +$2.08M ﹤0.01% 1716
2021
Q2 		$12.6M Hold
600,000
– – ﹤0.01% 1714
2021
Q1 		$9.32M Buy
600,000
+200,000
+50% +$3.87M ﹤0.01% 1802
2020
Q4 		$8.4M Sell
400,000
-80,769
-17% -$1.6M ﹤0.01% 1801
2020
Q3 		$9.71M Buy
+480,769
New +$10.6M ﹤0.01% 1717

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Norges Bank's DYN Position: Q1 2026 in Review

Norges Bank sold out of Dyne Therapeutics (DYN) in Q1 2026, closing a stake of 49,319 shares — an estimated $965K sold.

Norges Bank first reported a position in DYN in Q3 2020 and held it in 17 quarters. The position peaked at $22.4M in Q4 2024. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Norges Bank reported no remaining Dyne Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Norges Bank sold 49,319 Dyne Therapeutics shares in Q1 2026, an estimated $965K.
  • Norges Bank first reported a position in Dyne Therapeutics in Q3 2020 and held it in 17 quarters.
  • Norges Bank's Dyne Therapeutics position peaked at $22.4M in Q4 2024.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.